Open AccessAssociations of antiretroviral drug use and HIV-specific risk factors with carotid intima–media thickness
Author(s) -
Joseph A. Delaney,
Rebecca Scherzer,
Mary L. Biggs,
Michael G. Shliplak,
Joseph F. Polak,
Judith S. Currier,
Richard A. Kronmal,
Christine Wanke,
Peter Bacchetti,
Daniel H. O’Leary,
Phyllis C. Tien,
Carl Grünfeld
Publication year - 2010
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e32833d2132
Subject(s) - confounding , medicine , credible interval , intima media thickness , confidence interval , emtricitabine , cardiology , human immunodeficiency virus (hiv) , immunology , viral load , antiretroviral therapy , carotid arteries
Previous research has demonstrated an increase in carotid intima-media thickness (cIMT) in HIV-infected individuals compared to controls. However, the reason for this increased level of subclinical vascular disease is unknown.